Year |
Citation |
Score |
2023 |
Bremer PT, Burke EL, Barrett AC, Desai RI. Investigation of monoclonal antibody CSX-1004 for fentanyl overdose. Nature Communications. 14: 7700. PMID 38052779 DOI: 10.1038/s41467-023-43126-0 |
0.545 |
|
2019 |
Guenther S, Mickle TC, Barrett AC, Smith A, Braeckman R, Kelsh D, Vince B. Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users. Pain Medicine (Malden, Mass.). PMID 30986302 DOI: 10.1093/pm/pnz066 |
0.37 |
|
2016 |
Viscusi ER, Barrett AC, Paterson C, Forbes WP. Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis. Regional Anesthesia and Pain Medicine. 41: 93-8. PMID 26650429 DOI: 10.1097/AAP.0000000000000341 |
0.399 |
|
2015 |
Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP. Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain. Journal of Pain Research. 8: 771-780. PMID 26586963 DOI: 10.2147/JPR.S88203 |
0.664 |
|
2015 |
Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension. Journal of Palliative Medicine. 18: 593-600. PMID 25973526 DOI: 10.1089/jpm.2014.0362 |
0.461 |
|
2015 |
Nalamachu SR, Pergolizzi J, Taylor R, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials. Pain Practice : the Official Journal of World Institute of Pain. 15: 564-71. PMID 24815199 DOI: 10.1111/papr.12218 |
0.449 |
|
2007 |
Lomas LM, Barrett AC, Terner JM, Lysle DT, Picker MJ. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats. Psychopharmacology. 191: 273-85. PMID 17225166 DOI: 10.1007/S00213-006-0663-1 |
0.805 |
|
2006 |
Terner JM, Barrett AC, Lomas LM, Negus SS, Picker MJ. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains. Pain. 122: 90-101. PMID 16527399 DOI: 10.1016/J.Pain.2006.01.019 |
0.822 |
|
2006 |
Barrett AC. Low efficacy opioids: implications for sex differences in opioid antinociception. Experimental and Clinical Psychopharmacology. 14: 1-11. PMID 16503700 DOI: 10.1037/1064-1297.14.1.1 |
0.735 |
|
2003 |
Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain. 106: 381-91. PMID 14659521 DOI: 10.1016/J.Pain.2003.08.008 |
0.813 |
|
2003 |
Barrett AC, Smith ES, Picker MJ. Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer 344 rats. The Journal of Pharmacology and Experimental Therapeutics. 307: 237-45. PMID 12954802 DOI: 10.1124/Jpet.103.054478 |
0.808 |
|
2003 |
Barrett AC, Smith ES, Picker MJ. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox. The Journal of Pharmacology and Experimental Therapeutics. 305: 1061-70. PMID 12649297 DOI: 10.1124/Jpet.102.047068 |
0.745 |
|
2003 |
Terner JM, Barrett AC, Cook CD, Picker MJ. Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay. Behavioural Pharmacology. 14: 77-85. PMID 12576884 DOI: 10.1097/00008877-200302000-00008 |
0.791 |
|
2002 |
Barrett AC, Smith ES, Picker MJ. Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats. European Journal of Pharmacology. 452: 163-73. PMID 12354566 DOI: 10.1016/S0014-2999(02)02274-4 |
0.835 |
|
2002 |
Terner JM, Barrett AC, Grossell E, Picker MJ. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats. Psychopharmacology. 163: 183-93. PMID 12202965 DOI: 10.1007/S00213-002-1143-X |
0.865 |
|
2002 |
Barrett AC, Cook CD, Terner JM, Roach EL, Syvanthong C, Picker MJ. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception. Psychopharmacology. 160: 170-81. PMID 11875635 DOI: 10.1007/S00213-001-0949-2 |
0.863 |
|
2001 |
Barrett AC, Cook CD, Terner JM, Craft RM, Picker MJ. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids. Psychopharmacology. 158: 154-64. PMID 11702089 DOI: 10.1007/S002130100821 |
0.856 |
|
2001 |
Barrett AC, Morgan D, Izenwasser S, Picker MJ. Cocaine-like discriminative stimulus effects and [3H]dopamine uptake inhibition produced by selected partial opioid agonists. Behavioural Pharmacology. 12: 225-35. PMID 11548108 DOI: 10.1097/00008877-200107000-00001 |
0.759 |
|
2000 |
Cook CD, Barrett AC, Syvanthong C, Picker MJ. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats. Psychopharmacology. 152: 93-104. PMID 11041321 DOI: 10.1007/S002130000520 |
0.817 |
|
2000 |
Cook CD, Barrett AC, Syvanthong C, Picker MJ. Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat. Psychopharmacology. 152: 14-23. PMID 11041311 DOI: 10.1007/S002130000519 |
0.777 |
|
2000 |
Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology. 150: 430-42. PMID 10958085 DOI: 10.1007/S002130000453 |
0.863 |
|
1999 |
Smith MA, Barrett AC, Picker MJ. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor. Psychopharmacology. 143: 261-9. PMID 10353428 DOI: 10.1007/S002130050945 |
0.813 |
|
Show low-probability matches. |